
NEOGENOMICS INC
NEONASDAQ🏆 #1690 by market capEarnings Oct 27US Equity
$16.31▼ $0.22 (−1.36%)
Live1h—
24h▼ 1.4%
7d▲ 3.7%
14d▲ 6.7%
30d▲ 15.6%
1y▲ 167.5%
🏦Market Cap
$2.09B
Small Cap
📈Revenue Growth (YoY)
+11.2%
Healthy
📊Gross Margin
43.9%
Healthy
💵FCF Margin
1.6%
Thin
⚖️P/S Ratio
2.8x
Cheap
Otter Score
52
Weak
📊
Analyst Ratings
Price
$16.31
Total
29
Raised
4
Lowered
4
Avg PT
$19.00
H / L
$25 / $13
| Institution | Action | Rating | Date |
|---|---|---|---|
Needham | Reiterated | Buy | 2026-07-29 |
Benchmark | Reiterated | Buy | 2026-07-24 |
Leerink Partners | Upgraded | Market Perform → Outperform | 2026-04-29 |
TD Cowen | Reiterated | Buy | 2026-04-29 |
Piper Sandler | Reiterated | Overweight | 2026-02-24 |
Stephens & Co. | Reiterated | Overweight | 2025-09-02 |
Morgan Stanley | Reiterated | Equal Weight | 2025-07-30 |
William Blair | Downgraded | Outperform → Market Perform | 2025-07-29 |
Goldman Sachs | Reiterated | Buy | 2025-04-30 |
B of A Securities | Reiterated | Neutral | 2025-02-19 |
BTIG | Reiterated | Buy | 2024-05-02 |
Raymond James | Downgraded | Outperform → Market Perform | 2023-05-16 |
Cowen & Co. | Reiterated | Outperform | 2023-02-24 |
SVB Leerink | Reiterated | Outperform | 2022-11-09 |
Truist Securities | Reiterated | Buy | 2021-01-28 |
Guggenheim | Reiterated | Buy | 2020-08-28 |
Craig-Hallum | Reiterated | Buy | 2020-03-02 |
First Analysis | Upgraded | Outperform → Strong Buy | 2020-02-28 |
CIBC | Upgraded | Neutral → Outperform | 2019-03-12 |
Leerink Swann | Reiterated | Outperform | 2018-08-21 |
BTIG Research | Upgraded | Neutral → Outperform | 2018-04-16 |
Gabelli & Co. | Reiterated | Buy | 2017-08-24 |
Cantor Fitzgerald | Reiterated | Overweight | 2016-12-15 |
Axiom Capital | Downgraded | Hold → Sell | 2016-11-16 |
Janney Capital | Reiterated | Buy | 2016-01-08 |
Roth Capital | Reiterated | Buy | 2014-05-12 |
Longbow Research | Reiterated | Buy | 2014-05-12 |
Sidoti & Co. | Reiterated | Buy | 2013-05-01 |
Ladenburg Thalmann | Downgraded | Buy → Neutral | 2013-04-25 |
One row per institution, most recent rating